Christine Tranchant
- Neurology top 0.5%
- Molecular Biology top 5%
- Cellular and Molecular Neuroscience top 1%
- Neurology top 1%
- Genetics top 2%
- Co-authors
- Mathieu AnheimMichel KœnigPhilippe GajdosAndoni Echaniz‐LagunaSylvie ChevretClaude ChastangBernard ClairJ Warter
- Topics
- Genetic Neurodegenerative Diseases (58 papers)Parkinson's Disease Mechanisms and Treatments (44 papers)Neurological disorders and treatments (41 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Christine Tranchant
196 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 123
- Neurology 2.3k
- Molecular Biology 2.0k
- Cellular and Molecular Neuroscience 1.5k
- Neurology 701
- Genetics 464
Countries citing papers authored by Christine Tranchant
This map shows the geographic impact of Christine Tranchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Tranchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Tranchant more than expected).
Fields of papers citing papers by Christine Tranchant
This network shows the impact of papers produced by Christine Tranchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Tranchant. The network helps show where Christine Tranchant may publish in the future.
Co-authorship network of co-authors of Christine Tranchant
This figure shows the co-authorship network connecting the top 25 collaborators of Christine Tranchant. A scholar is included among the top collaborators of Christine Tranchant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Tranchant. Christine Tranchant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 15 | |
| 6 | 38 | |
| 7 | 43 | |
| 8 | 15 | |
| 9 | 25 | |
| 10 | 3 | |
| 11 | 28 | |
| 12 | La maladie de Lyme | 3 |
| 13 | 39 | |
| 14 | 99 | |
| 15 | 20 | |
| 16 | 19 | |
| 17 | 77 | |
| 18 | 16 | |
| 19 | 12 | |
| 20 | 70 |
About Christine Tranchant
Christine Tranchant is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology, having authored 209 papers that have together received 5.2k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (58 papers), Parkinson's Disease Mechanisms and Treatments (44 papers) and Neurological disorders and treatments (41 papers). The work is most often cited by research in Neurology (2.3k citations), Neurology (701 citations) and Cellular and Molecular Neuroscience (1.5k citations). Christine Tranchant has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Mathieu Anheim, Michel Kœnig, Philippe Gajdos, Andoni Echaniz‐Laguna, Sylvie Chevret, Claude Chastang, Bernard Clair, J Warter, Jean‐Marie Warter and Alexis Elbaz. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.